SCHEMBL4695505

SCHEMBL4695505

CS(=O)(=O)Oc1scc(Br)c1CC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 6/20 0.34
THRB P10828 6/20 0.33
EGLN1 Q9GZT9 1/20 0.33
THRA P10827 5/20 0.31
CA5A P35218 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811503 0.70 TSHR (0.42) THRBTHRA
SCHEMBL4697289 0.69 AKR1B1 (0.36) THRB
SCHEMBL4815057 0.62 BACE1 (0.48) PTGDR2
SCHEMBL979293 0.61 KDM4E (0.49) CA5A
SCHEMBL4811379 0.61 AKR1B1 (0.49) THRBTHRA
SCHEMBL4695111 0.60 MTNR1A (0.34) PTGDR2
SCHEMBL27866714 0.60 GABRA5 (0.43) PTGDR2THRBTHRA
SCHEMBL979826 0.59 KLK1 (0.51) CA5A
SCHEMBL11103498 0.59 CXCL8 (0.53)
SCHEMBL29188157 0.59 KDM4E (0.46) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569935-B1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS NOVEXEL (FR) 2008-08-20 EP disclosed
EP-1569935-A1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS Aventis Pharma S.A. (FR) 2005-09-07 EP disclosed
WO-2004052891-A1 HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREOF AND USE OF SAME AS MEDICAMENTS, SUCH AS ANTI-BACTERIAL MEDICAMENTS AND BETA-LACTAMASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-06-24 WO disclosed